
Real-world data get real dollars: GV, Bain help infuse $100M into Verana Health as pragmatic trial space heats up
As the application of real-world data in clinical practice and drug development becomes the reality for a growing number of physicians as well as drugmakers, GV and a marquee syndicate are betting some real dollars on one San Francisco player.
The crew formerly known as Google Ventures is leading a $100 million round for Verana Health, which has just acquired a smaller company specializing in large-scale data architecture solutions dubbed PYA Analytics. Bain Capital Ventures, Casdin Capital and Define Ventures also chipped in.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.